The DOI matches its Crossref record.
Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients
Open accessAbstract
Summary. Myelofibrotic transformation is a known complication of essential thrombocythaemia (ET), but information on its incidence, presenting features and evolution is scarce. In a series of 195 patients with ET followed for a median of 7·2 years (range: 1·9–24), evolution into myelofibrosis with myeloid metaplasia (MMM) occurred in 13 cases, a median of 8 years (range: 3·6–20·2) from diagnosis. The actuarial probability of this complication was 2·7% (95% CI: 2·4–2·9) at 5 years, 8·3% (95% CI: 7·8–8·9) at 10 years, and 15·3% (95% CI: 6·1–24·5) at 15 years. Four patients had not been treated before developing MMM. The main features indicating this condition were the appearance of immature myeloid precursors in the peripheral blood, a decrease in the Hb value not related to treatment and increased serum lactate dehydrogenase levels, followed by a progressive decrease in the platelet count, increasing leucocytosis and progressive splenomegaly. No patient had constitutional symptoms, and none of five evaluable cases showed chromosome abnormalities in bone marrow or unstimulated blood. After a median the myelofibrotic transformation, three patients have died and four have not required treatment for MMM as yet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Myeloproliferative Disorders
Campbell, P. J., & Green, A. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra063728 · Cited by 915
Barosi, G., Mesa, R. A., Thiele, J., Cervantes, F., Campbell, P. J., Verstovsek, S., Dupriez, B., Levine, R. L., Passamonti, F., Gotlib, J., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2404914 · Cited by 502
Self-citationMesa, R. A., Li, C.-Y., Ketterling, R. P., Schroeder, G. S., Knudson, R. A., & Tefferi, A. (2005) · Blood · doi:10.1182/blood-2004-07-2864 · Cited by 389
Wolanskyj, A. P., Schwager, S. M., McClure, R. F., Larson, D. R., & Tefferi, A. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.2.159 · Cited by 329
Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm
Beer, P. A., Delhommeau, F., LeCouédic, J.-P., Dawson, M. A., Chen, E., Bareford, D., Kušec, R., McMullin, M. F., Harrison, C. N., Vannucchi, A. M., et al. (2010) · Blood · doi:10.1182/blood-2009-08-236596 · Cited by 307
Metadata
- Authors
- Cervantes, F., Alvarez‐Larrán, A., Talarn, C., Gómez, M., & Montserrat, E.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2002-08-15
- Volume
- 118
- Issue
- 3
- Pages
- 786-790
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2095024333
- Cited by
- 159
- References
- 0
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. https://app.cochat.ai/papers/10.1046/j.1365-2141.2002.03688.x
- The paper
- Cervantes, F., Alvarez‐Larrán, A., Talarn, C., Gómez, M., & Montserrat, E. (2002). Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.2002.03688.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.